Tandem Diabetes Care Inc (TNDM)
30.81
+0.07
(+0.23%)
USD |
NASDAQ |
Nov 22, 16:00
30.90
+0.09
(+0.29%)
After-Hours: 20:00
Tandem Diabetes Care Revenue (Quarterly): 243.97M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 243.97M |
| June 30, 2024 | 221.91M |
| March 31, 2024 | 191.67M |
| December 31, 2023 | 196.80M |
| September 30, 2023 | 185.62M |
| June 30, 2023 | 195.92M |
| March 31, 2023 | 169.38M |
| December 31, 2022 | 220.50M |
| September 30, 2022 | 204.55M |
| June 30, 2022 | 200.26M |
| March 31, 2022 | 175.91M |
| December 31, 2021 | 210.00M |
| September 30, 2021 | 179.63M |
| June 30, 2021 | 172.14M |
| March 31, 2021 | 141.04M |
| December 31, 2020 | 168.06M |
| September 30, 2020 | 123.60M |
| June 30, 2020 | 109.24M |
| March 31, 2020 | 97.93M |
| December 31, 2019 | 108.40M |
| September 30, 2019 | 94.66M |
| June 30, 2019 | 93.26M |
| March 31, 2019 | 66.00M |
| December 31, 2018 | 76.20M |
| September 30, 2018 | 46.26M |
| Date | Value |
|---|---|
| June 30, 2018 | 34.13M |
| March 31, 2018 | 27.28M |
| December 31, 2017 | 40.30M |
| September 30, 2017 | 27.00M |
| June 30, 2017 | 21.33M |
| March 31, 2017 | 18.98M |
| December 31, 2016 | 28.91M |
| September 30, 2016 | 12.29M |
| June 30, 2016 | 22.98M |
| March 31, 2016 | 20.06M |
| December 31, 2015 | 29.12M |
| September 30, 2015 | 15.72M |
| June 30, 2015 | 15.71M |
| March 31, 2015 | 12.31M |
| December 31, 2014 | 17.89M |
| September 30, 2014 | 13.51M |
| June 30, 2014 | 10.26M |
| March 31, 2014 | 8.065M |
| December 31, 2013 | 10.24M |
| September 30, 2013 | 7.776M |
| June 30, 2013 | 5.528M |
| March 31, 2013 | 5.458M |
| December 31, 2012 | 2.257M |
| September 30, 2012 | 0.2177M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
97.93M
Minimum
Mar 2020
243.97M
Maximum
Sep 2024
175.83M
Average
182.62M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Masimo Corp | 504.60M |
| RxSight Inc | 35.31M |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 27.94M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.25M |
| Total Expenses (Quarterly) | 270.06M |
| EPS Diluted (Quarterly) | -0.35 |
| Enterprise Value | 1.899B |
| Gross Profit Margin (Quarterly) | 51.09% |
| Profit Margin (Quarterly) | -9.53% |
| Earnings Yield | -6.26% |
| Normalized Earnings Yield | -6.214 |